Affimed Eulerpool Ziņas

Affimed Akciju Ziņas

Affimed tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Affimed ziņas mēs apkopojam šeit.

• 17. decembris ·

  Yahoo
  Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)
• 9. decembris ·

  Yahoo
  Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer
• 8. decembris ·

  Yahoo
  Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients
• 6. decembris ·

  Yahoo
  FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy
• 5. decembris ·

  Yahoo
  Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)
• 15. novembris ·

  Yahoo
  Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ...
• 14. novembris ·

  SeekingAlpha
  Affimed N.V. (AFMD) Q3 2024 Earnings Call Transcript
• 14. novembris ·

  Yahoo
  Affimed N.V.: Q3 Earnings Snapshot
• 14. novembris ·

  Yahoo
  Affimed Reports Third Quarter 2024 Financial Results & Business Update
• 14. novembris ·

  SeekingAlpha
  Affimed N.V. 2024 Q3 - Results - Earnings Call Presentation